MetaCap

Abeona Therapeutics (ABEO) vs Oramed Pharmaceuticals (ORMP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Oramed Pharmaceuticals (ORMP) has outperformed Abeona Therapeutics (ABEO) over the past year, gaining 38.4% versus a loss of 46.0%. Over five years, ORMP leads with a -82.3% price change compared with -86.7% for ABEO. Abeona Therapeutics is the larger company by market cap ($165.3 million vs $155.2 million), about 1.1 times the size.

Oramed Pharmaceuticals converts more of its revenue into profit, with a net margin of 3202.5% versus 1223.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABEO-45.98%ORMP+38.37%
+115%+29%-57%
Nov 21, 20251 yearNov 20, 2026
ABEO-86.92%ORMP-86.53%
+5%-47%-98%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABEO versus ORMP key metrics
MetricABEOORMP
Share price$2.42$3.57
Market cap$165.31M$155.24M
1-day change-1.22%-3.25%
YTD return-54.08%+25.26%
1-year return-45.98%+38.37%
5-year return-86.74%-82.34%
P/E ratio (TTM)—1.05
EPS (TTM)$-1.16$3.41
Dividend yield0.00%7.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$5.82M$2.00M
Net income (latest FY)$71.18M$64.05M
Gross margin73.68%0.65%
Operating margin-1536.91%-754.40%
Net margin1223.08%3202.50%
52-week high$7.65$5.47
52-week low$2.09$2.52
Distance from 52-week high-68.37%-34.73%
Analyst consensusstrong_buynone
Avg. price target upside+542.98%+96.08%
Average volume1.66M173.38K
Shares outstanding68.31M43.49M
Employees226—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ORMP has outperformed ABEO by 84.4 percentage points over the past year.
  • Oramed Pharmaceuticals offers a meaningfully higher dividend yield (7.00% vs 0.00%).
  • Oramed Pharmaceuticals is more profitable, keeping 3202.5 cents of every revenue dollar as net income versus 1223.1 cents for Abeona Therapeutics.

About Abeona Therapeutics

ABEO stock →

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.

Health Care · Biotechnology: Pharmaceutical Preparations · 226 employees

About Oramed Pharmaceuticals

ORMP stock →

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

Health Care · Biotechnology: Pharmaceutical Preparations

ABEO vs ORMP FAQ

Which is bigger, Abeona Therapeutics or Oramed Pharmaceuticals?

Abeona Therapeutics (ABEO) is larger, with a market capitalization of $165.31M compared with $155.24M for Oramed Pharmaceuticals (ORMP).

Which stock has performed better over the past year, ABEO or ORMP?

ORMP returned +38.37% over the past 12 months, compared with -45.98% for ABEO (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Abeona Therapeutics or Oramed Pharmaceuticals?

Oramed Pharmaceuticals pays a dividend yielding 7.00%, while Abeona Therapeutics does not currently pay a regular dividend.

Are Abeona Therapeutics and Oramed Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons